Clinical Trials Directory

Trials / Unknown

UnknownNCT02112019

Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome

Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome; A Randomised Controlled Pilot Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Derk Jan Jager · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Sjögren's syndrome (SS) is an autoimmune inflammatory disorder of the exocrine glands. It particularly affects the lacrimal and salivary glands. Severe dry mouth and eyes are frequently reported as presenting symptoms. These symptoms are in many cases accompanied by nonspecific symptoms, such as malaise and fatigue. In addition, extraglandular manifestations, like purpura, polyneuropathy, and arthritis, can be present. SS affects mainly women with a female/male ratio of 9:1 and can occur at all ages. Due to the irreversible damage to the saliva producing cells, the quantity and quality of saliva reduces. The progressive nature of the syndrome results in a further reduction of salivary flow. Due to hyposalivation the patients suffer from progressive dental decay, dental erosion, severe dry mouth complaints (i.e. eating and swallowing problems, lack of taste), inflammation of the oral mucosa and lack of retention of removable dentures. Overall, this can be qualified as a reduction in the quality of life. Until now no effective (palliative) therapy to relieve dry mouth complaints is available. A recent case series study suggests that an endoscopic technique (sialoendoscopy) is able to alleviate the symptoms of patients suffering from SS. In this technique the ducts of the salivary glands are rinsed with saline and cortisone and possible strictures are dilated. It is hypothesised that performing a sialoendoscopic treatment will raise or restore (un)stimulated salivary flow levels and improve the reported mouthfeel score.

Conditions

Interventions

TypeNameDescription
PROCEDURESialoendoscopy
DRUGsaline
DRUGhydrocortisone

Timeline

Start date
2014-06-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2014-04-11
Last updated
2017-05-11

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02112019. Inclusion in this directory is not an endorsement.